Stay updated with breaking news from Nasdaq crsp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SFE Investment Counsel purchased a new stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 4,900 shares of the company’s stock, valued at approximately $307,000. Other large investors have also recently modified their holdings of […] ....
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s stock price dropped 5.4% during mid-day trading on Wednesday . The company traded as low as $60.31 and last traded at $61.69. Approximately 842,038 shares changed hands during trading, a decline of 55% from the average daily volume of 1,875,040 shares. The stock had previously closed at […] ....
Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) shot up 3.3% on Thursday . The stock traded as high as $67.20 and last traded at $66.75. 377,631 shares were traded during mid-day trading, a decline of 80% from the average session volume of 1,903,866 shares. The stock had previously closed at $64.60. Wall […] ....
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) shares traded down 1.1% during trading on Friday . The company traded as low as $62.82 and last traded at $64.32. 573,275 shares traded hands during trading, a decline of 70% from the average session volume of 1,898,067 shares. The stock had previously closed at $65.06. Analyst […] ....
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s stock price dropped 0.1% during mid-day trading on Wednesday . The company traded as low as $63.60 and last traded at $64.94. Approximately 326,042 shares changed hands during trading, a decline of 83% from the average daily volume of 1,919,327 shares. The stock had previously closed at […] ....